Emerging Regulatory Issues in Genomic Medicine

Venue: Hotel Royal Pedregal

Location: Mexico City, Mexico

Event Date/Time: Mar 25, 2008
Report as Spam


The purpose of this meeting is to identify synergies and common issues in Genomic Medicine and to develop common approaches to address these issues. The FDA has a major effort in the area of genomics and personalized medicine. It is working with clinicians, the pharmaceutical industry, and other regulatory agencies worldwide to integrate genomic medicine into medical practice.